HK61686A - Aroylimidazolones and analogues thereof - Google Patents

Aroylimidazolones and analogues thereof Download PDF

Info

Publication number
HK61686A
HK61686A HK616/86A HK61686A HK61686A HK 61686 A HK61686 A HK 61686A HK 616/86 A HK616/86 A HK 616/86A HK 61686 A HK61686 A HK 61686A HK 61686 A HK61686 A HK 61686A
Authority
HK
Hong Kong
Prior art keywords
aroylimidazolones
analogues
aroylimidazole
cardiotonics
ones
Prior art date
Application number
HK616/86A
Other languages
English (en)
Inventor
C. Dage Richard
P. Palopoli Frank
A. Schnettler Richard
Martin Grisar J.
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of HK61686A publication Critical patent/HK61686A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK616/86A 1981-03-05 1986-08-21 Aroylimidazolones and analogues thereof HK61686A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use

Publications (1)

Publication Number Publication Date
HK61686A true HK61686A (en) 1986-08-29

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
HK616/86A HK61686A (en) 1981-03-05 1986-08-21 Aroylimidazolones and analogues thereof

Country Status (18)

Country Link
US (1) US4405628A (enExample)
EP (1) EP0059948B1 (enExample)
KR (1) KR890000765B1 (enExample)
AT (1) ATE16489T1 (enExample)
AU (1) AU557590B2 (enExample)
CA (1) CA1190550A (enExample)
DE (1) DE3267352D1 (enExample)
DK (1) DK168627B1 (enExample)
ES (2) ES510087A0 (enExample)
GB (1) GB2096600B (enExample)
GR (1) GR76518B (enExample)
HK (1) HK61686A (enExample)
IE (1) IE52387B1 (enExample)
IL (1) IL65137A (enExample)
MY (1) MY8600700A (enExample)
NO (1) NO157175C (enExample)
NZ (1) NZ199885A (enExample)
PH (1) PH18345A (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
CA1262732C (en) * 1984-07-30 1989-11-07 PREPARATION OF 1,3-DIHYDRO-4-PYRIDOYL-2H-IMIDAZOL-2-ONES
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
WO1992000282A1 (en) * 1990-06-29 1992-01-09 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
HK1218629A1 (zh) 2013-02-25 2017-03-03 Bausch Health Ireland Limited 用於结肠清洁的鸟苷酸环化酶受体激动剂
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
US20160184387A1 (en) 2013-08-09 2016-06-30 Dominique Charmot Compounds and methods for inhibiting phosphate transport
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
GB2096600B (en) 1985-06-05
NZ199885A (en) 1985-04-30
ES8402827A1 (es) 1984-03-01
GB2096600A (en) 1982-10-20
DK95482A (da) 1982-09-06
AU557590B2 (en) 1986-12-24
US4405628A (en) 1983-09-20
DK168627B1 (da) 1994-05-09
AU8103782A (en) 1982-09-09
EP0059948A1 (en) 1982-09-15
DE3267352D1 (en) 1985-12-19
IE820491L (en) 1982-09-05
PH18345A (en) 1985-06-05
NO157175B (no) 1987-10-26
EP0059948B1 (en) 1985-11-13
ATE16489T1 (de) 1985-11-15
IE52387B1 (en) 1987-10-14
NO820686L (no) 1982-09-06
NO157175C (no) 1988-02-03
KR890000765B1 (ko) 1989-04-05
GR76518B (enExample) 1984-08-10
ES8305352A1 (es) 1983-04-16
ES519254A0 (es) 1984-03-01
IL65137A0 (en) 1982-05-31
IL65137A (en) 1987-02-27
CA1190550A (en) 1985-07-16
MY8600700A (en) 1986-12-31
KR830009046A (ko) 1983-12-17
ES510087A0 (es) 1983-04-16

Similar Documents

Publication Publication Date Title
HK61686A (en) Aroylimidazolones and analogues thereof
JPS5581845A (en) Amino acid derivative as antihypertensive
ZA8580B (en) Substituted malonic acid derivatives,processes for their preparation,and their use as pest-combating agents
EP0179808A4 (en) MEDICINAL COMPOSITION SUITABLE FOR TREATING OR PROPHYLAXIS OF HEART DISORDERS.
ATE7387T1 (de) Herstellung des calciumsalzes von alpha-hydroxy- gamma-methylmercaptobuttersaeure.
NO864514D0 (no) Fremgangsmaate for fremstilling av thiazoloner.
IL72617A0 (en) Pyridazinylcarboxylic acid derivatives,their preparation and their use as gametocides
EP0167936A3 (en) Use of actinonin as an immunopotentiator
CA1269383C (en) HERBICIDAL ESTERS OF 2,6-BIS-FLUOROMETHYLDIHYDROPYRIDINE-3,5-DICARBOXYLIC ACID
ATE79615T1 (de) Cardiotonische phenyloxazolone.
DE3460730D1 (en) Esters of 2-methylpentanoic acid, their preparation and use as flavouring compounds, and flavouring compositions containing these compounds
ATA188385A (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
NO164599C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt.
FI843592A7 (fi) Cryptococcus-lajia olevista hiivoista peräisin oleva L-aminohappo-oksidaasi, sen valmistus ja käyttö.
EP0219112A3 (en) Cardiotonic aroylthiazolones
GR862445B (en) Process for the preparation of ranitidine or acid addition salts thereof
EP0192327A3 (en) Use of phosphonoformic acid and its esters and salts for the manufacture of a medicament for the treatment of AIDS
IL72474A0 (en) Halogenoalkylcarbamic acid esters,their preparation and their use as pesticides
IT8324141A0 (it) Preparato per la cura delle ustioni.
DK694987A (da) 1-cyclyl- eller polycyclylsubstituerede 1h-imidazol-5-carboxylsyrer
ZA871829B (en) The use of asymmetric 2-pyridyl-phosphoric acid esters as selective fungicides
ZA855340B (en) Use of o-substituted pyruvic acid oximes for the prophylaxis and/or treatment of heart and circulatory diseases,as well as corresponding medicaments
NO166078C (no) Fremgangsmaate for fremstilling av 16-fenoksy- og 16-substituerte fenoksyprostatriensyrederivater.
BE794239A (en) Caffeine dithiosalicylate - analgesic antipyretic and antiarrhythmic
NO851195L (no) Fremgangsmaate for fremstilling av askorbinsyreestere.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)